To ask the Secretary of State for Health with reference to the answer to Lord Walton of Detchant of 26 March 2012, Official Report, House of Lords, column 208WA, on in-vitro diagnostic tests, whether he has any plans to require health institutions to report adverse incidents with in-house pathology tests...

To ask the Secretary of State for Health with reference to the answer to Lord Walton of Detchant of 26 March 2012, Official Report, House of Lords, column 208WA, on in-vitro diagnostic tests, whether he has any plans to require health institutions to report adverse incidents with in-house pathology tests...

(3) if he will consider making it his policy that all GPs should inform women who have undergone breast screening of their breast density.

(3) if he will consider making it his policy that all GPs should inform women who have undergone breast screening of their breast density.

(2) what information his Department holds on the correlation between breast density and the five-year survival rate for women with breast cancer;

(2) what information his Department holds on the correlation between breast density and the five-year survival rate for women with breast cancer;

To ask the Secretary of State for Health (1) what estimate he has made of the proportion of women who have had mammograms who subsequently have been informed of their breast density;

To ask the Secretary of State for Health (1) what estimate he has made of the proportion of women who have had mammograms who subsequently have been informed of their breast density;

To ask the Secretary of State for Health pursuant to the answer of 26 March 2012, Official Report, column 987W, on genetics: screening, what the nature is of the shared strategic framework that his Department plans to put in place.

To ask the Secretary of State for Health pursuant to the answer of 26 March 2012, Official Report, column 987W, on genetics: screening, what the nature is of the shared strategic framework that his Department plans to put in place.

To ask the Secretary of State for Health (1) what proportion of mammogram screenings for women who are under 50, pre menopausal and have dense breasts were analysed digitally in the latest period for which figures are available;

To ask the Secretary of State for Health (1) what proportion of mammogram screenings for women who are under 50, pre menopausal and have dense breasts were analysed digitally in the latest period for which figures are available;

To ask the Secretary of State for Health if he will take steps to ensure that GPs are aware of the warning signs of obstructive sleep apnoea and are screened for that condition using (a) the Epworth sleepiness test or (b) other recognised tests.

To ask the Secretary of State for Health if he will take steps to ensure that GPs are aware of the warning signs of obstructive sleep apnoea and are screened for that condition using (a) the Epworth sleepiness test or (b) other recognised tests.

To ask the Secretary of State for Health whether data on breast density are routinely monitored and collected by GPs.

To ask the Secretary of State for Health whether data on breast density are routinely monitored and collected by GPs.

(2) what the detection rate for mammograms are for breast tissue classified as (a) fatty replaced, (b) scattered density, (c) heterogeneously dense and (d) extremely dense.

(2) what the detection rate for mammograms are for breast tissue classified as (a) fatty replaced, (b) scattered density, (c) heterogeneously dense and (d) extremely dense.

To ask the Secretary of State for Health (1) if he will make it his policy to make a test for leukodystrophies a part of standard perinatal procedure; and if he will make a statement;

To ask the Secretary of State for Health (1) if he will make it his policy to make a test for leukodystrophies a part of standard perinatal procedure; and if he will make a statement;

To ask Her Majesty's Government how widely available in-vitro diagnostic tests are in the National Health Service; and how such testing is regulated.

To ask Her Majesty's Government how widely available in-vitro diagnostic tests are in the National Health Service; and how such testing is regulated.

To ask Her Majesty's Government what are the groups of diseases or other health-related issues for which in-house pathology tests using in-vitro methods have been developed in the National Health Service.

To ask Her Majesty's Government what are the groups of diseases or other health-related issues for which in-house pathology tests using in-vitro methods have been developed in the National Health Service.

To ask the Secretary of State for Health what assessment he has made of the usefulness of (a) predictive and (b) predisposition genetic tests.

To ask the Secretary of State for Health what assessment he has made of the usefulness of (a) predictive and (b) predisposition genetic tests.

Today, the Prime Minister launches his challenge on dementia to tackle one of the most important issues we face arising from an ageing population. The challenge sets out the Government's ambition to increase diagnosis rates, raise awareness and understanding and to strengthen substantially our research efforts. Dementia is one of...

Today, the Prime Minister launches his challenge on dementia to tackle one of the most important issues we face arising from an ageing population. The challenge sets out the Government's ambition to increase diagnosis rates, raise awareness and understanding and to strengthen substantially our research efforts. Dementia is one of...

My right honourable friend the Secretary of State for Health (Andrew Lansley) has made the following Written Ministerial Statement. Today, the Prime Minister launches his challenge on dementia to tackle one of the most important issues we face arising from an ageing population. The challenge sets out the Government's ambition...

My right honourable friend the Secretary of State for Health (Andrew Lansley) has made the following Written Ministerial Statement. Today, the Prime Minister launches his challenge on dementia to tackle one of the most important issues we face arising from an ageing population. The challenge sets out the Government's ambition...

To ask Her Majesty's Government whether the use of in-vitro diagnostic tests in the National Health Service has led to any serious issues or problems; and, if so, to which regulatory authority any such incidents have been reported.

To ask Her Majesty's Government whether the use of in-vitro diagnostic tests in the National Health Service has led to any serious issues or problems; and, if so, to which regulatory authority any such incidents have been reported.

To ask the Secretary of State for Health (1) if he will take steps to improve access to tests to support the earlier diagnosis of short-lasting unilateral neuralgiform headache with conjunctival infection and tearing and episodic cluster headaches;

To ask the Secretary of State for Health (1) if he will take steps to improve access to tests to support the earlier diagnosis of short-lasting unilateral neuralgiform headache with conjunctival infection and tearing and episodic cluster headaches;

To ask the Secretary of State for Health (1) what steps he is taking to promote GP awareness of tuberculosis incidence and the importance of early detection;

To ask the Secretary of State for Health (1) what steps he is taking to promote GP awareness of tuberculosis incidence and the importance of early detection;

To ask the Secretary of State for Health what estimate he has made of the number of people with diabetes who did not receive the nine health care checks recommended by the National Institute for Health and Clinical Excellence guidelines in each primary care trust area in 2011.

To ask the Secretary of State for Health what estimate he has made of the number of people with diabetes who did not receive the nine health care checks recommended by the National Institute for Health and Clinical Excellence guidelines in each primary care trust area in 2011.